Impact of deep sequencing on hepatocellular carcinoma utilizing high-throughput technology

In the medical sciences, bioinformatics typically include compiling expression data for cells affected by various diseases, like cancer. Hepatocellular carcinoma (HCC) is a tumor of the liver, which is generally emerging in the setting of chronic liver diseases. Clinical behavior of hepatocellular c...

Full description

Saved in:
Bibliographic Details
Published inNetwork modeling and analysis in health informatics and bioinformatics (Wien) Vol. 9; no. 1; p. 35
Main Authors Hashem, Esraa M., Mabrouk, Mai S., Eldeib, Ayman M.
Format Journal Article
LanguageEnglish
Published Vienna Springer Vienna 01.12.2020
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In the medical sciences, bioinformatics typically include compiling expression data for cells affected by various diseases, like cancer. Hepatocellular carcinoma (HCC) is a tumor of the liver, which is generally emerging in the setting of chronic liver diseases. Clinical behavior of hepatocellular carcinoma is difficult to estimate. Therefore, there is a critical demand to obtain new techniques that can assess the prognosis of hepatic cancer patients. Methods: this work produces a genomic study that spotlights on applying bioinformatics technologies to predict and deal with the molecular reasons for hepatocellular carcinoma by the examination whole-genome sequence of the chromosomal variations of the genomic copy number to grand correct diagnoses of this kind of disease. In this study, next-generation sequence (NGS) is utilized by applying OncoSNP-SEQ technique to a number of human chromosomes for analyzing hepatic cancer data that identify genome-wide mutations in copy number of the genomic information data. The outcomes referred to a certain number of chromosome aberrations detected with significant genes such as : SHC, TCP1, CCT3 , SHC1, EPHA5, UGT2B28, UBE1L2, and also strike ( CREB3L4, RAB1, MAGI2 ) genes which are discovered lately in 2013 , tumor suppressors SHC1 and CKS1B, LRP1B , as well as oncogene UBE1L2 , all of which may play a central role in cancer cell survival during the progress of metastases. Recently, the development of next-generation sequence empowers simultaneous assessment of copy number of hundred thousands of locales in a genome, more precise estimation of copy numbers, higher coverage, accurate confirmation of change points, and higher tendency to distinguish new alteration regions.
ISSN:2192-6662
2192-6670
DOI:10.1007/s13721-020-00242-x